parkinson-disease

Documents about parkinson-disease

• Omics research in Parkinson's disease: evolution, integrated analysis, pathogenic mechanisms, biomarkers, and therapeutic targets.#418299NCBI PubMed Central
• Explainable machine learning for the prediction of motor fluctuations and Levodopa-induced dyskinesias in Parkinson's disease#435639bioRxiv / medRxiv
• Breaking barriers and fighting inequality in Parkinson's disease care: Personal reflections of movement disorders clinicians.#437167NCBI PubMed Central
• Exploring MAPT-containing H1 and H2 haplotypes in Parkinson's disease across diverse populations.#442903NCBI PubMed Central
• Bridging Gaps in Spanish-speaking Individuals in Rural Areas about Parkinson’s disease#443609Scholarly Commons
• A task-aligned multimodal machine learning framework for studying working memory dysfunction in Parkinson's disease.#455137NCBI PubMed Central
• Orthostatic hypotension and acute cognitive dysfunction in Parkinson's disease: insights from functional near-infrared spectroscopy.#610184NCBI PubMed Central
• A Dynamical Digital Twin Unmasks Hidden Neuromotor Control Policies and Catastrophic Tipping Points in Parkinson's Disease#627785bioRxiv / medRxiv
• Parkinsonian gait improvement through vibratory stride parameter feedback#651786Europe PMC
• Association Between Progression in Parkinson's Disease and Metabolic Syndrome#672822UR Research
• Movement Disorders Analysis Using a Deep Learning Approach#806591ClinicalTrials.gov
• Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)#825032ClinicalTrials.gov
• Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate#829284ClinicalTrials.gov
• Validity and Reliability of the Turkish Version of the Manual Dexterity Questionnaire#860651ClinicalTrials.gov
• Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research#840349ClinicalTrials.gov
• Effects of physical exercise on cognitive impairment in patients with Alzheimer's disease, Parkinson's disease or mild cognitive impairment: a systematic review and meta-analysis.#288888NCBI PubMed Central
• Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy#803648ClinicalTrials.gov
• Enhanced meta ensemble stacking approach with XGBoost and optuna based detection of Parkinson's disease.#1371NCBI PubMed Central
• Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease.#9030NCBI PubMed Central
• AI-Enabled Flexible Sensing Ecosystems for Parkinson’s Disease: Advancing Digital Biomarkers and Closed-Loop Interventions.#9450NCBI PubMed Central
• Comparative Analysis of Task-Specific and Combined Upper-Limb EMG Features for Early Parkinson's Disease Classification#18833bioRxiv / medRxiv
• Serum albumin and uric acid: biomarkers of neurocognitive and physical function in early Parkinson's disease.#30819NCBI PubMed Central
• Neutrophil-to-Lymphocyte Ratio Predicts Infusion-Site Skin Nodules in Parkinson Disease Patients Receiving Foslevodopa/Foscarbidopa Subcutaneous Infusion#131042bioRxiv / medRxiv
• Predicting long term clinical outcomes in Parkinson’s Disease using short term rating scales#142953Unpaywall
• Varying patterns of association between cortical large-scale networks and subthalamic nucleus activity in Parkinson's disease.#152130NCBI PubMed Central
• Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment#180563Springer Nature OA
• Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs.#186079NCBI PubMed Central
• Investigating Molecularly Defined Clusters of Parkinson’s Disease Based on Multi-Omics Data With Clinical and Biological Implications#202400Harvard DASH
• A comparative analysis of health-related and individual quality of life in people with Parkinson’s disease.#209585NCBI PubMed Central
• Lorazepam-induced full resolution of catatonia and psychosis in Parkinson's disease with acromegaly: a case report.#209652NCBI PubMed Central
• Assessing ageing, cognitive ability and freezing of gait in Parkinson's disease through integrated brain-heart network dynamics#216680bioRxiv / medRxiv
• Perceived Consequences and Catastrophising Help Explain Health-Related Quality of Life in Parkinson Disease. A Cross-Sectional Study.#230275bioRxiv / medRxiv
• Efficacy and Safety of Electroacupuncture on Insomnia in Parkinson's Disease: A Multicentre, Randomized, Controlled Trial.#236313NCBI PubMed Central
• Clinical Laboratory Evaluation of Chronic Autonomic Failure#253086ClinicalTrials.gov
• Age, emotional burden and deep brain stimulation electrode location shape Parkinson's disease quality of life#268320Europe PMC
• The α-Synuclein seeding assay discriminates between LRRK2 p.Gly2019Ser variant carriers with and without Parkinson's disease.#272011bioRxiv / medRxiv
• The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention.#292221NCBI PubMed Central
• Experiences of Anxiety and Its Relationship to Freezing of Gait in Parkinson's Disease: A Qualitative Study.#295048NCBI PubMed Central
• Art-based interventions and non-motor outcomes in Parkinson's disease: a systematic review and meta-analysis.#297398NCBI PubMed Central
• A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National Cohort.#320634NCBI PubMed Central
• Exploring fNIRS-guided neurofeedback for supplementary motor area training in Parkinson's disease and healthy older adults.#322868NCBI PubMed Central
• Selective amygdala subregional atrophy in Parkinson's disease: from subjective cognitive decline to mild cognitive impairment.#360598NCBI PubMed Central
• Cutting-edge transformer-based deep learning for Parkinson's disease diagnosing using multimodal hand-drawing and handwriting analysis.#371446NCBI PubMed Central
• Frequency-dependent cognitive effects of Deep Brain Stimulation in Parkinson's Disease: A Systematic Review and Meta-Analysis#373569bioRxiv / medRxiv
• Repurposing Ezetimibe As A Therapeutic For Parkinson's Disease: Evaluating The Therapeutic Potential And Probing For A Mechanism#376932EliScholar
• Licensed Subcutaneous Infusion Therapies in Advanced Parkinson’s Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis#377997HAL (France)
• Multilevel functional network signature of Pisa syndrome in Parkinson's disease: a resting-state fMRI study.#418431NCBI PubMed Central
• Predictive Models for Motor Outcomes From Deep Brain Stimulation in Parkinson's Disease: A Systematic Review.#420987NCBI PubMed Central
• Trafficking Deficiency of TMEM175 Variants in Parkinson's Disease Pathogenesis and the Prospects of Precision Medicine.#421078NCBI PubMed Central
• Deep Brain Stimulation Withdrawal Syndrome in Parkinson’s Disease: Clinical Features and Outcomes of Two New Cases.#421197NCBI PubMed Central